Orgenesis Granted FDA Orphan Drug Designation for Autologous Insulin Producing Cells in the Treatment of Severe Hypoglycemia-Prone Diabetes Resulting from Total Pancreatectomy June 17, 2019 - NASDAQ Companies 0 » View More News for June 17, 2019